EVERMORE WOMEN'S HEALTH
LIVE

Serial Number

99622753

Owner

Kristen Wolfe, M.D. PLLC

Attorney

Patricia L Vannoy

First Use Date

Dec 23, 2025

Filing Date

Jan 29, 2026

Add to watchlist:

No watchlists yet
View on USPTO

EVERMORE WOMEN'S HEALTH Trademark

Serial Number: 99622753

EVERMORE WOMEN'S HEALTH is a trademark filed by Kristen Wolfe, M.D. PLLC on January 29, 2026. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Kristen Wolfe, M.D. PLLC (2 trademarks)

1114 Neon Forest Circle Unit 6
Longmont, CO 80504

Entity Type: 16

Trademark Details

Filing Date

January 29, 2026

Registration Date

Not Registered

First Use Anywhere

December 23, 2025

First Use in Commerce

January 20, 2026

Goods & Services

International Class 44: Medical care; Consulting services in the field of women's health; Consulting in the fields of health, wellness, and nutrition for women; Consulting in the fields of health, wellness, and nutrition for menopause; Consulting in the fields of health, wellness, and nutrition for perimenopause; Consulting in the fields of health, wellness, and nutrition for individuals in their midlife; Consulting in the fields of health, wellness, and nutrition for sexual health; Consulting in the fields of health, wellness, and nutrition for well-woman care; Consulting in the fields of health, wellness, and nutrition for longevity; Consulting in the fields of health, wellness, and nutrition for health optimization; Consulting in the fields of health, wellness, and nutrition for cancer survivorship; Consulting services in the field of medical care; Multi-disciplinary, integrative, outpatient health care delivery and medical consultations; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; Provision of medical services by health care professionals via the internet or telecommunication networks; Providing personalized healthcare and medical information in the nature of women's health information; Providing medical information in the field of women's health; Providing medical advice in the field of women's health; Providing personalized healthcare and medical information in the nature of menopause care information; Providing personalized healthcare and medical information in the nature of perimenopause care information; Providing personalized healthcare and medical information in the nature of sexual health information; Providing personalized healthcare and medical information in the nature of midlife care information; Providing personalized healthcare and medical information in the nature of well-woman care information; Providing personalized healthcare and medical information in the nature of longevity information; Providing personalized healthcare and medical information in the nature of health optimization information; Providing personalized healthcare and medical information in the nature of cancer survivorship information; Providing medical information in the field of sexual health; Providing medical information in the field of well-woman care; Providing medical information in the field of longevity; Providing medical information in the field of health optimization; Providing medical information in the field of cancer survivorship; Providing medical information in the field of health for individuals in their midlife; Providing medical information in the field of menopause; Providing medical information in the field of perimenopause; Providing medical advice in the field of menopause; Providing medical advice in the field of perimenopause; Providing medical advice in the field of midlife health; Providing medical advice in the field of sexual health; Providing medical advice in the field of well-woman care; Providing medical advice in the field of longevity; Providing medical advice in the field of health optimization; Providing medical advice in the field of cancer survivorship

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2026 CNRT
ASSIGNED TO EXAMINER
May 28, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 21, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 29, 2026 MAFR
NEW APPLICATION ENTERED
Jan 29, 2026 NWAP